Day 1 — Wednesday, March 6, 2024 |
Plenary Session |
8:30–9:00 | Registration & Welcome Coffee Hyperion Hotel Basel, Messeplatz 12, Basel, Switzerland |
9:00–9:10 | Opening Remarks Jana Hersch, Head of Corporate Scientific Engagement, Genedata, Boston, MA, USA |
9:10–9:30 | Work Smarter, Not Harder: Leveraging Data to Increase Efficiency Othmar Pfannes, CEO, Genedata, Basel, Switzerland |
9:30–10:00 | Evolution of the Genedata Biologics Ecosystem at Pfizer: RNA and Beyond Joel Bard, Associate Research Fellow BioMedicine Design, Pfizer, Cambridge, MA, USA |
10:00–10:30 | Genedata Expressionist at the Biologics Research Center, Novartis Basel: Automating and Digitalizing MS Analytics Patrick Schindler, Senior Principal Scientist, Novartis, Basel, Switzerland |
10:30–11:00 | Break |
11:00–11:30 | Embracing Change: Digitalizing Antibodies, Cell & Gene Therapies, and More at AstraZeneca Carl Matthews, Principal Scientist Biologics Engineering, AstraZeneca, Great Abington, United Kingdom |
11:30–12:00 | Digitalizing ADC Workflows with Genedata at Merck Sameh Eid, Principal Scientist Research Informatics, Merck, Darmstadt, Germany |
12:00–12:30 | Streamlining Lab Execution Workflows with Genedata Rik Rademaker, Director Cell and Molecular Sciences, Genmab, Utrecht, The Netherlands |
12:30–2:00 | Lunch Hyperion Hotel Basel |
Breakout Sessions |
| BIOTHERAPEUTICS DISCOVERY & DEVELOPMENT Biologics & Bioprocess | ASSAY ANALYSIS & MANAGEMENT Screener | MASS-SPEC DATA ANALYSIS Expressionist | PRECISION MEDICINE Profiler | NGS-BASED DEVELOPMENT & BIOSAFETY Selector |
2:00–2:30 | Genedata Biologics at the Center of Sanofi’s Large Molecules Research Katja Kroll, Digital Biologics Platform Site Lead, Sanofi, Frankfurt am Main, Germany | High-Throughput Screening of NANOBODY® Molecules Using a Genedata Screener – Biologics Integrated Workflow Tom Raes, Scientist Automation & Data Management, Sanofi, Ghent, Belgium | Genedata at Janssen: A Brief History, Current and Future Directions with Focus on Genedata Expressionist Steven Pomerantz, Principal Scientist, Janssen, Spring House, PA, USA | From Lab Automation to Data Standardization and Modeling Ismael Velasco, Director Global Data Systems GDD TRD Data Assets & Insights, Novartis, Basel, Switzerland Marc Flesch, Head of Genedata Profiler, Genedata, Munich, Germany | From Sequences to Insights: Genetic Characterization of Cell Lines Using NGS Benjamin Lindner, Senior Data Scientist, Boehringer Ingelheim, Biberach, Germany |
2:30–3:00 | Leveraging Genedata Biologics in the Discovery and Characterization of TCRs for Adoptive Cell Therapy Lisa Eisenberg, Senior Scientist Machine Learning, Immatics Biotechnologies, Tübingen, Germany | Efficient Analysis of Drug Combination in Oncology Therapeutic Discovery Elodie Monceau, Associate Scientist, and Anthony Boisbouvier, Business Analyst Pharmacology, Servier Research Institute, Saclay, France | Peptide Mapping for the Masses: Rolling Out Data Processing to Less Experienced Users Will Burkitt, Associate Director, UCB, Slough, United Kingdom | Expanding the Genedata Biopharma Platform with Self-Service Data Science Andreas Biegert, Software Engineering Lead, Genedata, Munich, Germany | Genedata Selector 10 Roadmap: Path to Fully Automated NGS Assays with Playbooks Ludwig Macko, Head of Genedata Selector Development, Genedata, Basel, Switzerland |
3:00–3:30 | A Lean and Smart Approach for Setting Up an Antibody Development Platform Gregory Mouret, USP Scientist, Ferring Biologics Innovation Centre, Lausanne, Switzerland | Genedata Screener 21 Further Accelerates Project Cycles and Elevates Output Quality Matthias Fassler, Product Manager Genedata Screener, Genedata, Basel, Switzerland | Streamlining Data Analysis in LC-MS MAM Workflows Patrick Merkle, Senior Expert, Novartis, Basel, Switzerland | Deciphering the Immune System's Complexity with Single-Cell and Spatial Analysis Daniel Poeschl, Clinical Data Scientist, Genedata, Basel, Switzerland | NGS Implementation for Adventitious Virus Detection – from Investigation to Quality Control Aurora Signorazzi, Scientist & Project Leader, Janssen, Leiden, The Netherlands |
3:30–4:00 | Unifying Antibody Library Workflows Including NGS Analysis in Genedata Biologics Nathalie George, Investigator, Novartis, Basel, Switzerland | A Window to the RNA Landscape: Optimizing Analysis of Gene Expression Assays at Axxam Samuel Bradberry, Principal Scientist Data Science, Axxam, Milan, Italy | Genedata Expressionist at Biologics Research Center (BRC) Basel Christian Hug & Emilie Muller, Heloise Hensinger & Thierry Besson, Novartis, Basel, Switzerland | | The NGS Analysis Pipelines for Virus Detection in Biologics Izabela Fabianska, Scientist Development Analytics, IDT Biologika, Dessau-Rosslau, Germany |
4:00–4:15 | Break |
4:15–5:30 | Demo and Poster Session Meet the Experts – Check out our demos and view posters. Demos are approximately 5–10 minutes and will be repeated on demand throughout the session. |
Breakout Sessions |
| BIOTHERAPEUTICS DISCOVERY & DEVELOPMENT Biologics & Bioprocess | NGS-BASED DEVELOPMENT & BIOSAFETY Selector |
5:30–6:00 | Automation of Upstream Process Development in Genedata Bioprocess at Biotalys Jolien Van Poucke, Technology Lead USP, Biotalys, Ghent, Belgium | Enabling the Validation of NGS-Based Characterization and Release Assays Marcell Veidner, Business Account Manager, Genedata, Basel, Switzerland |
6:00–6:30 | Roadmap Genedata Biologics & Genedata Bioprocess Christoph Freiberg, Head of Science, Genedata, Basel, Switzerland Guido Cappuccilli, Product Manager, Genedata, Basel, Switzerland | Panel Discussion: NGS in an Evolving Regulatory Landscape
|
7:00 | Dinner Restaurant Kunsthalle, Steinenberg 7, 4051 Basel |